Jacob M. Chacko, M.D.

Jacob M. Chacko, M.D.

President and Chief Executive OfficeratOric Pharmaceuticals· In proxies 2022–2025

Pay in FY2025+5% from the year before · Oric Pharmaceuticals stock +1.4% the same year

Jacob M. Chacko, M.D. was paid $5.6M in FY2025 (Dec), up 5%. Oric Pharmaceuticals stock rose 1.4% that year.

Pay$100 in the stock at the end of FY21 → $56
Pay is from the Summary Compensation Table of each Oric Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Oric PharmaceuticalsPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role -41%
  2. Bright Peak Therapeutics, Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  3. 4D Molecular Therapeutics, Inc.Public company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years
  4. Turning Point Therapeutics, Inc.Public company · 3 yr
    • Director2018 – 2021 · 3 yrNo stock prices for these years
  5. Bonti, Inc.Public company · Less than 1 yr
    • Director2018 – 2018 · Less than 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?